These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35737276)

  • 1. Granulocyte-colony stimulating factor (G-CSF): an emerging therapeutic approach for amyotrophic lateral sclerosis (ALS).
    Vafaei Mastanabad M; Nooraei A; Hassan Zadeh Tabatabaei MS; Akbari Fakhrabadi A; Jafarzadeh F
    Acta Neurol Belg; 2023 Jun; 123(3):763-771. PubMed ID: 35737276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro.
    Rando A; Gasco S; de la Torre M; García-Redondo A; Zaragoza P; Toivonen JM; Osta R
    Neurodegener Dis; 2017; 17(1):1-13. PubMed ID: 27544379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis - a pilot study.
    Iberl S; Meyer AL; Müller G; Peters S; Johannesen S; Kobor I; Beier F; Brümmendorf TH; Hart C; Schelker R; Herr W; Bogdahn U; Grassinger J
    Cytokine; 2019 Aug; 120():192-201. PubMed ID: 31100684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
    Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
    Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis.
    Grassinger J; Khomenko A; Hart C; Baldaranov D; Johannesen SW; Mueller G; Schelker R; Schulte-Mattler W; Andreesen R; Bogdahn U
    Cytokine; 2014 May; 67(1):21-8. PubMed ID: 24680478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS).
    Cashman N; Tan LY; Krieger C; Mädler B; Mackay A; Mackenzie I; Benny B; Nantel S; Fabros M; Shinobu L; Yousefi M; Eisen A
    Muscle Nerve; 2008 May; 37(5):620-5. PubMed ID: 18335482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
    Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
    Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial.
    Duning T; Schiffbauer H; Warnecke T; Mohammadi S; Floel A; Kolpatzik K; Kugel H; Schneider A; Knecht S; Deppe M; Schäbitz WR
    PLoS One; 2011 Mar; 6(3):e17770. PubMed ID: 21423758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
    Chiò A; Mora G; La Bella V; Caponnetto C; Mancardi G; Sabatelli M; Siciliano G; Silani V; Corbo M; Moglia C; Calvo A; Mutani R; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Bondesan P; Garbelli S; Mantovani S; Bendotti C; Tarella C;
    Muscle Nerve; 2011 Feb; 43(2):189-95. PubMed ID: 21254083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis.
    Zhang Y; Wang L; Fu Y; Song H; Zhao H; Deng M; Zhang J; Fan D
    Amyotroph Lateral Scler; 2009; 10(5-6):430-1. PubMed ID: 19922135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice.
    Henriques A; Pitzer C; Dupuis L; Schneider A
    BMC Neurosci; 2010 Feb; 11():25. PubMed ID: 20178614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection through G-CSF: recent advances and future viewpoints.
    Rahi V; Jamwal S; Kumar P
    Pharmacol Rep; 2021 Apr; 73(2):372-385. PubMed ID: 33389706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
    Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
    Hofer M; Vacek A; Weiterová L
    Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.
    Johannesen S; Budeus B; Peters S; Iberl S; Meyer AL; Kammermaier T; Wirkert E; Bruun TH; Samara VC; Schulte-Mattler W; Herr W; Schneider A; Grassinger J; Bogdahn U
    Front Neurol; 2018; 9():971. PubMed ID: 30534107
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.
    Nefussy B; Artamonov I; Deutsch V; Naparstek E; Nagler A; Drory VE
    Amyotroph Lateral Scler; 2010; 11(1-2):187-93. PubMed ID: 19449238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
    Henriques A; Pitzer C; Dittgen T; Klugmann M; Dupuis L; Schneider A
    Mol Ther; 2011 Feb; 19(2):284-92. PubMed ID: 21139572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived inducible microglia-like cells ameliorate motor function and survival in a mouse model of amyotrophic lateral sclerosis.
    Kobashi S; Terashima T; Katagi M; Urushitani M; Kojima H
    Cytotherapy; 2022 Aug; 24(8):789-801. PubMed ID: 35393241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice.
    Yamasaki R; Tanaka M; Fukunaga M; Tateishi T; Kikuchi H; Motomura K; Matsushita T; Ohyagi Y; Kira J
    J Neuroimmunol; 2010 Dec; 229(1-2):51-62. PubMed ID: 20659772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.